GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » New Ray Medicine International Holding Ltd (HKSE:06108) » Definitions » Other Current Receivables

New Ray Medicine International Holding (HKSE:06108) Other Current Receivables : HK$0.95 Mil (As of Dec. 2023)


View and export this data going back to 2013. Start your Free Trial

What is New Ray Medicine International Holding Other Current Receivables?

New Ray Medicine International Holding's Other Current Receivables for the quarter that ended in Dec. 2023 was HK$0.95 Mil.

New Ray Medicine International Holding's quarterly Other Current Receivables increased from Dec. 2022 (HK$0.00 Mil) to Jun. 2023 (HK$0.43 Mil) and increased from Jun. 2023 (HK$0.43 Mil) to Dec. 2023 (HK$0.95 Mil).

New Ray Medicine International Holding's annual Other Current Receivables declined from Dec. 2021 (HK$0.81 Mil) to Dec. 2022 (HK$0.00 Mil) but then increased from Dec. 2022 (HK$0.00 Mil) to Dec. 2023 (HK$0.95 Mil).


New Ray Medicine International Holding Other Current Receivables Historical Data

The historical data trend for New Ray Medicine International Holding's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

New Ray Medicine International Holding Other Current Receivables Chart

New Ray Medicine International Holding Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Current Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.24 0.19 0.81 - 0.95

New Ray Medicine International Holding Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.81 0.57 - 0.43 0.95

New Ray Medicine International Holding Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.


New Ray Medicine International Holding Other Current Receivables Related Terms

Thank you for viewing the detailed overview of New Ray Medicine International Holding's Other Current Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


New Ray Medicine International Holding (HKSE:06108) Business Description

Traded in Other Exchanges
N/A
Address
19 Dangui Road, B-C, 37th Floor, Dikai International Center, Hangzhou, CHN
New Ray Medicine International Holding Ltd is engaged in the trading of pharmaceutical products in the People's Republic of China. The company's segments include Distribution and trading of pharmaceutical products and Provision of marketing and promotion services. Distribution and trading of pharmaceutical products consist of Injection drugs, Capsules and Granule drugs, Tablet drugs and Other Drugs. It generates a majority of its revenue from the distribution of Injection Drugs.
Executives
Dai Xiaosong
Eagle Amber Holdings Limited
Chu Xueping 2201 Interest of corporation controlled by you
Qian Shenglei 2101 Beneficial owner
Zhang Jiang 2201 Interest of corporation controlled by you
Yang Fang 2202 Interest of your spouse
Zhou Ling 2101 Beneficial owner

New Ray Medicine International Holding (HKSE:06108) Headlines

No Headlines